Residency · Moreno Valley, CA
Sponsored by Riverside University Health System
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 468 citations · Raymond Huang
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.
Neuro-oncology · 2023 · 210 citations · Raymond Huang
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
Neuro-oncology · 2025 · 50 citations · Raymond Huang
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0.
European journal of nuclear medicine and molecular imaging · 2024 · 57 citations · Raymond Huang
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.
Neuro-oncology · 2022 · 149 citations · Raymond Huang
The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
Neuro-oncology · 2024 · 75 citations · Raymond Huang
A generalizable foundation model for analysis of human brain MRI.
Nature neuroscience · 2026 · 9 citations · Raymond Huang
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.
Neuro-oncology · 2022 · 82 citations · Raymond Huang